Advertisement
Videos
Advertisement

What New Diagnoses Could Mean for Pharma Industry

Wed, 06/05/2013 - 8:48am

Changes to the DSM-5, the updated manual of psychiatric illnesses released earlier this month, include 15 new disorders. The Wall Street Journal’s Jen Wieczner looks at how these new disorders could spell new market opportunities for Big Pharma.

Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading